TRENDING :  Market Movers  |  Top 50   SPY (0.88%)    CGC (-1.42%)    CASY (0.88%)    BABA (1.16%)    BA (-0.02%)    ATVI (2.76%)    ARCW (3.48%)    APC (0.11%)    SCIF (-0.33%)    RYAAY (-2.06%)    RIOT (9.52%)    PG (-3.34%)    PANW (0.49%)    PAGS (1.48%)    MU (-0.86%)    MMYT (-0.74%)    MJ (-0.19%)    MHK (1.63%)    MBRX (-45.31%)    INTC (-0.15%)    GOOGL (1.37%)    GDXJ (-0.11%)    FRT (0.88%)    FIS (0.77%)    EWZ (1.29%)

 DVA - DaVita Inc.

$53.00 [1.9][3.72%]

Next Earnings

5/2/2019

AMC

Recommend
Trade Idea »



OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $DVA

TRENDING ARTICLES



Wednesday Sector Laggards: Healthcare, Materials

04/17/19
In afternoon trading on Wednesday Healthcare stocks are the worst performing sector showing a 4 0 loss Within that group Alexion Pharmaceuticals Inc Symbol ALXN and DaVita Inc Symbol DVA are two large stocks that are lagging showing a loss of 8 9 and 8 0 respectively

Noteworthy Wednesday Option Activity: AAPL, WCG, DVA

04/10/19
Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Apple Inc Symbol AAPL where a total volume of 333 515 contracts has been traded thus far today a contract volume which is representative of approximately 33 4

Here's Why You Should Hold on to DaVita (DVA) Stock Now

04/10/19
DaVita Inc DVA is gaining prominence in the MedTech space courtesy of its incessant efforts to upgrade services global expansion initiatives and acquisitions The company has a market capitalization of approximately 9 17 billion The stock currently carries a Zacks Rank 3

Fresenius Medical's New Hemodialysis Software Gets FDA Nod

03/25/19
Fresenius Medical Care AG amp Co KGaA FMS recently announced that the FDA has approved its computer assisted ultrafiltration control software which aims at improving fluid management during hemodialysis HD This further fortifies the company s foothold in the global renal medical